×

Positive for Regeneron: Cramer

9:55 AM ET Fri, 17 Oct 2014

CNBC's Jim Cramer discusses news Regeneron's drug Eylea for treating diabetic macular edema created significantly greater improvement in visual acuity compared with Lucentis.